Celldex Therapeutics Inc (NASDAQ:CLDX)

0.6337
Delayed Data
As of May 25
 -0.0039 / -0.61%
Today’s Change
0.62
Today|||52-Week Range
3.26
-77.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-118.1M-127.2M-128.5M-93.0M
 
 
 
 
 
Depreciation3.4M4.0M4.1M5.3M
 
 
 
 
 
Total Other Cash Flow7.0M13.4M18.0M-5.0K
 
 
 
 
 
Funds From Operations-107.7M-109.8M-106.5M-87.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-6.1M-10.9M6.6M12.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-101.5M-98.9M-113.0M-99.9M
 
 
 
 
 
 
InvestingIncrease In Investments-148.3M-206.4M-175.7M-171.0M
 
 
 
 
 
Decrease In Investments109.2M161.1M242.8M219.2M
 
 
 
 
 
Capital Expenditures-1.9M-4.9M-2.8M-1.8M
 
 
 
 
 
Fixed Asset Disposal0.000.004.6M0.00
 
 
Net Cash Flow Investing-41.0M-50.2M68.9M46.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.00188.8M14.5M51.3M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.2M4.3M0.000.00
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing1.2M193.2M14.5M51.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-5.0K15.0K0.000.00
 
 
 
 
Net Change In Cash-141.4M44.1M-29.6M-2.2M